What is Afton Scientific?
Afton Scientific operates as a US-based pharmaceutical contract development and manufacturing organization (CDMO) with a specialized focus on the sterile filling of small-volume injectable drugs. Boasting over three decades of industry experience, the company excels in handling small-batch commercial products and clinical trial materials. Afton Scientific is recognized for its commitment to delivering projects on time and cultivating robust client relationships, offering comprehensive contract manufacturing and laboratory services. Their operational model emphasizes regulatory compliance, stringent quality control, and a flexible approach that enables rapid scheduling and tailored solutions to meet the specific needs of pharmaceutical clients.
How much funding has Afton Scientific raised?
Afton Scientific has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Afton Scientific
PPP
Public-Private Partnership
What's next for Afton Scientific?
The substantial capital infusion, indicated by the $350K in total funding and the recent $350K strategic investment, positions Afton Scientific for accelerated growth and enhanced service capabilities. As a company deeply entrenched in the niche of sterile filling for small-volume injectables, this backing is likely to fuel expansions in manufacturing capacity, technological advancements in sterile processing, and potentially broader market reach. The company's established track record in regulatory compliance and quality assurance, coupled with its agility in handling clinical trial materials and small-batch commercial products, suggests a strategic focus on deepening its expertise and solidifying its role as a key partner for pharmaceutical innovators requiring specialized manufacturing solutions.
See full Afton Scientific company page
